Skip to content

Fat loss caused by some anti-HIV drugs persists in the long term

Body fat changes in people with HIV: a clinical review

Body fat changes in people with HIV: a clinical review

US study confirms long-term use of AZT, d4T result in lipoatrophy

How frequently are ARV side-effects being seen in resource-limited settings, and how are they dealt with?

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

Switch to tenofovir better than change to abacavir?

Switching to abacavir restores some fat loss over 2 years, but other body disturbances unchanged

NNRTI patients switched to Trizivir show lipid improvements

HIV-positive teenagers with lipodystrophy have lower growth hormone secretion